GIST Recurrence Risk Underestimated 'in a Third of Patients'GIST Recurrence Risk Underestimated 'in a Third of Patients'

Many patients with resected gastrointestinal stromal tumors (GIST) are missing out on recommended adjuvant therapy. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news